FERRI, NICOLA

FERRI, NICOLA  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 20 di 255 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Bempedoic acid and increased serum uric acid levels: a matter of concern? 2026 Luca BonanniGiorgia MarodinCamilla PortinariPaolo SimioniNicola Ferri + NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES - -
Hemostatic Aspects of Interactions between Anticancer Drugs and Oral Anticoagulants in Patients with Cancer-Associated Venous Thromboembolism 2026 Ferri N. + SEMINARS IN THROMBOSIS AND HEMOSTASIS - -
Mesenchymal Stem Cell-Derived Extracellular Vesicles in Myocardial Ischemia–Reperfusion Injury: A Comprehensive Review 2026 Bonanni L.Ferri N. BIOLOGY - -
Mesenchymal Stromal Cells at the Interface of Hemostasis and Immunothrombosis 2026 Bonanni L.Ferri N.Simioni P. BIOLOGY - -
New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9 2026 Ferri N. + EUROPEAN HEART JOURNAL SUPPLEMENTS - -
Optimizing Treatment in Homozygous Familial Hypercholesterolemia: Monocentric Observational Clinical Study on Efficacy and Safety of Evinacumab and Lomitapide Combination 2026 Maria Giovanna LupoGiorgia MarodinCamilla PortinariAlberto ZambonPaolo SimioniNicola Ferri + JOURNAL OF CLINICAL LIPIDOLOGY - -
PCSK9 switches partner inside the vascular wall: from LDL receptor to LRP1 2026 Ferri N. + ATHEROSCLEROSIS - -
Potentially Clinically Significant Drug-Drug Interactions in Older Adults with Atrial Fibrillation and Multimorbidity: Prevalence, Correlates, and Association with Adverse Clinical Outcomes in a Swedish National Register-Based Study 2026 Ferri, Nicola + CARDIOVASCULAR DRUGS AND THERAPY - -
Quality of life, care needs and priorities in atrial fibrillation: the impact of number and patterns of comorbidities 2026 Ravelli A.Sergi G.Buja A.Ferri N. + QUALITY OF LIFE RESEARCH - -
The 2025 ESC/EAS Dyslipidaemia Focused Update: Clinical Interpretation and Practical Implications 2026 Bonanni L.Ferri N. + CARDIOVASCULAR DRUGS AND THERAPY - -
The role of comorbidity and frailty in shaping the burden of atrial fibrillation: a multinational cross-sectional survey 2026 Ravelli A.Sergi G.Buja A.Ferri N. + SCIENTIFIC REPORTS - -
Antioxidant Activity and Potential Cholesterol Modulating Effect of <i>Punica granatum</i> L. Peel Hydroethanolic Extract 2025 Rossi I.Ferri N.Dall'Acqua S. + CHEMISTRY & BIODIVERSITY - -
Bempedoic Acid and the Uric Acid Paradox: Reflections on the Recent Meta-analysis 2025 Ferri, Nicola + CARDIOVASCULAR DRUGS AND THERAPY - -
Clinical pharmacology of combination therapies for the prevention and treatment of cardiovascular diseases 2025 Ferri N. + GIORNALE ITALIANO DI CARDIOLOGIA - -
Comorbidity and medication patterns in atrial fibrillation patients: association with adverse clinical outcomes 2025 Celik, DilekSergi, GiuseppeFerri, Nicola + INTERNAL AND EMERGENCY MEDICINE - -
Do Anti-PCSK9 Monoclonal Antibodies Have Pleiotropic Effects? 2025 Ferri N. JACC. BASIC TO TRANSLATIONAL SCIENCE - -
Drug–Drug Interactions Between DAAs and Anticoagulants or Antiplatelets: A Position Paper of the Italian Anticoagulation Clinics 2025 Ferri N. + LIVER INTERNATIONAL - -
Effects of ‘Mapo’ tangelo (Citrus x tangelo) extracts, essential oil, and isolated compounds on LDL receptor and PCSK9 expression in human hepatocarcinoma cell line Huh7 2025 Ferrarese, IreneLupo, Maria GiovannaRossi, IlariaMarodin, GiorgiaSut, StefaniaFerri, NicolaDall'Acqua, Stefano + FOOD & FUNCTION - -
Emerging oral therapeutic strategies for inhibiting PCSK9 2025 Ferri N.Marodin G. ATHEROSCLEROSIS PLUS - -
Exploring patient engagement in atrial fibrillation with multimorbidity: impact on quality of life, medication adherence and healthcare perceptions - a multicountry cross-sectional study 2025 Ferri N. + BMJ OPEN - -